Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Patel

Showing results (591-600 of 596) with videos related to

Pageof 60
Sort By:
You have reached the last page of results.This site can display upto 596 results.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> studyLee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
The Lancet. Infectious Diseases|March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Cesar A Arias, Lauren Komarow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global RegionsMinggui Wang, Lizhao Ge, Liang Chen, et al.
The Lancet. Infectious Diseases|November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, Michelle Earley, Liang Chen, et al.
The Lancet. Microbe|February 12, 2023
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort studyJinnethe Reyes, Lauren Komarow, Liang Chen, et al.
Science Translational Medicine|September 14, 2022
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infectionsMark A T Blaskovich, Karl A Hansford, Mark S Butler, et al.
Pageof 60

Showing results (591-600 of 596) with videos related to

Sort By:
Pageof 60
You have reached the last page of results.This site can display upto 596 results.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> studyLee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
The Lancet. Infectious Diseases|March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Cesar A Arias, Lauren Komarow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global RegionsMinggui Wang, Lizhao Ge, Liang Chen, et al.
The Lancet. Infectious Diseases|November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, Michelle Earley, Liang Chen, et al.
The Lancet. Microbe|February 12, 2023
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort studyJinnethe Reyes, Lauren Komarow, Liang Chen, et al.
Science Translational Medicine|September 14, 2022
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infectionsMark A T Blaskovich, Karl A Hansford, Mark S Butler, et al.
Pageof 60